drugset
drugset / Press release

MacroGenics to Receive $10 Million Milestone Payment from Servier for Dosing the First Patient in a Phase 1 Dose Expansion Trial of MGA271

2013-08-20 · MacroGenics · original macrogenics.com ↗

Enoblituzumab

MacroGenics to Receive $10 Million Milestone Payment from Servier for Dosing the First Patient in a Phase 1 Dose Expansion Trial of MGA271 14.4 KB

The release as fetched from its publisher. macrogenics.com ↗